Skip to main content

Advertisement

Log in

Diagnosis and Treatment of Hypertension in Children

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension is a global problem, affecting both developed and developing nations. In children and adolescents, hypertension has gained ground in cardiovascular medicine, thanks to the progress made in several areas of pathophysiologic and clinical research. Childhood hypertension is often asymptomatic and is easily missed, even by health professionals. Target organ damage is detectable in children and adolescents. Management of hypertension includes lifestyle changes and pharmacologic treatment. In the case of secondary hypertension, pharmacologic treatment usually is required. In essential hypertension, assessment of early organ damage provides a useful tool for treatment decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance ••Of major importance

  1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004,114(2 Suppl):555–576.

    Google Scholar 

  2. •• Lurbe E, Cifkova R, Cruickshank JK, et al.; European Society of Hypertension: Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009, 27:1719–1742. These guidelines represent a consensus among specialists involved in the detection and control of high blood pressure in children and adolescents. The guidelines synthesize a considerable amount of scientific data and clinical experience and represent best clinical wisdom, upon which physicians, nurses, and families should base their decisions. They call attention to the burden of hypertension in children and adolescents and its contribution to the current epidemic of cardiovascular disease. These guidelines should encourage public policy makers to develop a global effort to improve the identification and treatment of high blood pressure among children and adolescents.

  3. Raitakari OT, Juonala M, Kähönen M, et al.: Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277–2283.

    Article  CAS  PubMed  Google Scholar 

  4. Sun SS, Grave GD, Siervogel RM, et al.: Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 2007, 119:237–246.

    Article  PubMed  Google Scholar 

  5. • Falkner B, Lurbe E, Schaefer F: High blood pressure in children: clinical and health policy implications. J Clin Hypertens 2010, 12:261–276. This report aims to increase awareness of the problem of hypertension in childhood. Recent reports on prevalence and target organ injury are discussed, and health policy initiatives to improve blood pressure control are proposed.

  6. Menghetti E, Virdis R, Strambi M, et al.: Blood pressure in childhood and adolescence: the Italian normal standards. Study Group on Hypertension of the Italian Society of Pediatrics. J Hypertens 1999, 17:1363–1372.

    CAS  Google Scholar 

  7. Park MK, Menard SM, Schoolfield J: Oscillometric blood pressure standards for children. Pediatr Cardiol 2005, 26:601–607.

    Article  CAS  PubMed  Google Scholar 

  8. Jackson LV, Thalange NK, Cole TJ: Blood pressure centiles for Great Britain. Arch Dis Child 2007, 92:298–303.

    Article  PubMed  Google Scholar 

  9. Harshfield GA, Wilson ME: Ethnic differences in childhood blood pressure. In Pediatric Hypertension. Edited by Portman RJ, Sorof JM, Ingelfinger JR. Totowa, NJ: Humana Press; 2004:293–305.

  10. Sorof JM, Lai D, Turner J, et al.: Overweight, ethnicity and the prevalence of hypertension in school-aged children. Pediatrics 2004, 113:475–482.

    Article  PubMed  Google Scholar 

  11. National Heart, Lung, and Blood Institute: Report of the Second Task Force on Blood Pressure Control in Children—1987. Pediatrics 1987, 79:1–25.

    Google Scholar 

  12. Sinaiko AR, Gomez-Marin O, Prineas RJ: Prevalence of “significant” hypertension in junior high school-aged children: the Children and Adolescent Blood Pressure Program. J Pediatr 1989, 114:664–669.

    Article  CAS  PubMed  Google Scholar 

  13. Wühl E, Witte K, Soergel M, et al.; German Working Group on Pediatric Hypertension: Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002, 20:1995–2007.

    Article  PubMed  Google Scholar 

  14. Sorof JM, Poffenbarger T, Franco K, Portman R: Evaluation of white-coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 2001, 14:855–860.

    Article  CAS  PubMed  Google Scholar 

  15. Pickering TG, Davidson K, Gering W, Schwartz JE: Masked hypertension. Hypertension 2002, 40:795–796.

    Article  CAS  PubMed  Google Scholar 

  16. Mancia G: Reversed white-coat hypertension: definition, mechanisms and prognostic implications. J Hypertens 2002, 20:579–581.

    Article  CAS  PubMed  Google Scholar 

  17. Sorof JM, Portman RJ: White coat hypertension in children with elevated casual blood pressure. J Pediatr 2000, 137:493–497.

    Article  CAS  PubMed  Google Scholar 

  18. Lurbe E, Torro I, Alvarez V, et al.: Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005, 45:493–498.

    Article  CAS  PubMed  Google Scholar 

  19. Stergiou GS, Yiannes NG, Rarra VC, Panagiotakos DB: Home blood pressure normalcy in children and adolescents: the Arsakeion School study. J Hypertens 2007, 25:1375–1379.

    Article  CAS  PubMed  Google Scholar 

  20. Vogt BA: Hypertension in children and adolescents: definition, pathophysiology, risk factors and long-term sequelae. Current Therap Res 2001, 62:283–297.

    Article  Google Scholar 

  21. Goonasekera CDA, Dillon MJ: Measurement and interpretation of blood pressure. Arch Dis Child 2000, 82:261–265.

    Article  CAS  PubMed  Google Scholar 

  22. Lurbe E, Redon J: Secondary hypertension in children and adolescents. In Secondary Hypertension. Edited by Mansoor G. Totowa, NJ: Humana Press; 2004:274–304.

  23. Zubrow AB, Hulman S, Kushner H, Falkner B: Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. J Perinatol 1995, 15:470–479.

    CAS  PubMed  Google Scholar 

  24. Flynn J: Neonatal hypertension: diagnosis and management. Pediatr Nephrol 2000, 14:332–341.

    Article  CAS  PubMed  Google Scholar 

  25. Kay JD, Sinaiko AR, Daniels SR: Pediatric hypertension. Am Heart J 2001, 142:422–432.

    Article  CAS  PubMed  Google Scholar 

  26. Luma GB, Spiotta RT: Hypertension in children and adolescents. Am Fam Physician 2006, 73:1558–1568.

    PubMed  Google Scholar 

  27. Dillon MJ: The diagnosis of renovascular disease. Pediatr Nephrol 1997, 11:366–372.

    Article  CAS  PubMed  Google Scholar 

  28. Swinford RD, Portman RJ: Diagnostic evaluation of pediatric hypertension. In Pediatric Hypertension. Edited by Portman RJ, Sorof JM, Ingelfinger JR. Totowa, NJ: Humana Press; 2004:405–420.

  29. Brewer ED: Evaluation of hypertension in childhood diseases. In Pediatric Nephrology. Edited by Avner ED, Harmon WE, Niaudet P. Philadelphia: Lippincott Williams & Wilkins; 2004:1179–1197.

  30. Devereux RB, Alonso DR, Lutas EM, et al.: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450–458.

    Article  CAS  PubMed  Google Scholar 

  31. de Simone G, Devereux RB, Daniels SR, et al.: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056–1062.

    Article  PubMed  Google Scholar 

  32. Daniels SR, Kimball TR, Morrison JA, et al.: Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 1995, 76:699–701.

    Article  CAS  PubMed  Google Scholar 

  33. Hanevold C, Waller J, Daniels S, et al.; International Pediatric Hypertension Association: The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004, 113:328–333.

    Article  PubMed  Google Scholar 

  34. Litwin M, Niemirska A, Sladowska J, et al.: Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 2006, 21:811–819.

    Article  PubMed  Google Scholar 

  35. McNiece KL, Gurpa-Malhotra M, Samuels J, et al.; National High Blood Pressure Education Program Working Group: Left ventricular hypertrophy in hypertensive adolescents. Analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension 2007, 50:392–395.

    Google Scholar 

  36. Sorof JM, Alexandrov AV, Garami Z, et al.: Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 2003, 18:1020–1024.

    Article  PubMed  Google Scholar 

  37. Zhu W, Huang X, He J, et al.: Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. Eur J Pediatr 2005, 164:337–344.

    Article  PubMed  Google Scholar 

  38. Jourdan C, Wühl E, Litwin M, et al.: Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005, 23:1707–1715.

    Article  CAS  PubMed  Google Scholar 

  39. Sinha MD, Reid CJ: Evaluation of blood pressure in children. Curr Opin Nephrol Hypertens 2007, 16:577–584.

    Article  PubMed  Google Scholar 

  40. Assadi F: Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol 2008, 29:580–584.

    Article  PubMed  Google Scholar 

  41. Torrance B, McGuire KA, Lewanczuk R, McGavock J: Overweight, physical activity and high blood pressure in children: a review of the literature. Vasc Health Risk Manag 2007, 3:139–149.

    PubMed  Google Scholar 

  42. Salminen M, Vahlberg T, Kivela SL: Effects of family-oriented risk-based prevention on serum cholesterol and blood pressure values of children and adolescents. Scand J Prim Health Care 2005, 23:34–41.

    Article  PubMed  Google Scholar 

  43. Addison CC, Jenkins BW, White MS, Young L: Implementation of a cardiovascular disease prevention program among school-aged children: a pilot study. Int J Environ Res Public Health 2006, 3:274–277.

    Article  PubMed  Google Scholar 

  44. Hayman LL, Meininger JC, Daniels SR, et al.: Primary prevention of cardiovascular disease in nursing practice: focus on children and youth: a scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2007, 116:344–357.

    Article  PubMed  Google Scholar 

  45. Regulation (EC) No. 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 27/12/2006.

  46. • Simonetti G, Rizzi M, Donadini R, Bianchetti MG: Effects of antihypertensive drugs on blood pressure and proteinuria in childhood. J Hypertens 2007, 25:2370–2376. The blood pressure reduction of ACE inhibitors, ARBs, and calcium-channel blockers is almost identical. In children with pathologic proteinuria, ACE inhibitors or ARBs are superior to calcium-channel blockers.

  47. • Kupferman JC, Paterno K, Mahgerefteh J, et al.: Improvement of left ventricular mass with antihypertensive therapy in children with hypertension. Pediatr Nephrol 2010, 25:1513–1518. This study demonstrates that LVH in hypertensive children improves with effective blood pressure control.

    Google Scholar 

  48. •• ESCAPE Trial Group, Wühl E, Trivelli A, et al.: Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639–1650. Intensified blood pressure control, with target 24-hour blood pressure levels in the low range of normal, confers a substantial benefit with respect to renal function among children with chronic kidney disease. Reappearance of proteinuria after initial successful pharmacologic blood pressure control is common among children who are receiving long-term ACE inhibition.

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Empar Lurbe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lurbe, E., Álvarez, J. & Redon, J. Diagnosis and Treatment of Hypertension in Children. Curr Hypertens Rep 12, 480–486 (2010). https://doi.org/10.1007/s11906-010-0155-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-010-0155-x

Keywords

Navigation